PLE1F-Porcine Liver Esterase

Added to your cart

PLE1F-Porcine Liver Esterase

Cart subtotal: £0.00

View cart (0) Checkout

#SKU PLE1F

Get in touch to purchase this product

Contact our team of experts to discuss your requirements

Contact our expert team

Product Details

Porcine Liver Esterase (PLE) is used in Urinalysis controls as a partial substitute for Human Leukocyte Esterase. Leukocyte esterase test is a urine test for the presence of white blood cells and other abnormalities associated with an infection of the urinary tract. PLE acts on water-soluble carboxyl esters containing short chain fatty acids. PLE has a molecular weight of 168kDa. Porcine Esterase is used in Urinalysis, Asymmetric Ester Hydrolysis, Research, Life Science and Assay Manufacturing. Control manufacturers use porcine esterase for the detection of esterase levels in urine to indicate infection. It is also commonly used for kinetic resolutions and asymmetric synthesis in organic chemistry. In addition, in pharmaceutical and industrial applications it is used to catalyse the hydrolysis of pentaacetyl catechin and epicatechin.
PLE1F

More information

Attributes

Description

  • Lead Time
  • 9 weeks
  • Storage
  • Store desiccated at -15C or below. Allow to come
  • Shelf Life
  • 6 months
  • Manufacturer Country
  • UK
  • Source
  • Porcine liver
  • Activity
  • ≥75 U/mg material
  • EC Number
  • 3.1.1.1
  • Systematic Name
  • Carboxy-ester hydrolase
  • Unit Definition
  • That amount of enzyme which hydrolyses 1.0 µmole of ethyl butyrate to butyric acid and ethanol per minute at 25C and pH 8.0.
  • Form
  • A freeze-dried preparation

Technical Documents

Product Specification (54.87KB)

Analytical Procedures (151.13KB)

Product Information (357.96KB)

Sorry, no results found.

Enter the full lot number and hit enter.

BBI Solutions Brands

diarect.png

The acquisition of DIARECT in June 2020 and their world leading recombinant autoimmune antigen capability immediately enhances BBI’s portfolio and position as a ‘complete’ immunoassay reagent supplier. This further enhances BBI’s position as the world’s largest diagnostics components company with a market leading antigen portfolio.

mbs.png

Maine Biotechnology Services brings 27 years of knowledge, experience, process development, and project management to our customers to ensure the best possible antibodies for any application. As antibody development goals in the biotechnology and pharmaceutical industry have evolved the acquisition of MBS will help BBI further meet and exceed our customers needs.

Newsletter

Signup for our newsletter to receive the latest BBI Solutions updates and special offers in your inbox